Matthew L Posard's Net Worth
Matthew L Posard's net worth is estimated to be at least $4,065,013.50 as of 11/23/2024. CoreStreet's estimation of Matthew L Posard's net worth is based on their sale of stock and current holding of stock.
Matthew L Posard is Director at Halozyme Therapeutics Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 9,881 units of HALO stock on 08/14/2024. Their biggest sale was on 12/02/2022 when they sold 10,000 units of Halozyme Therapeutics Inc stock for $588,000.00. They typically trade 2 times per year.
Total value of insider buys:
- $1,091,391.00
Total value of insider sells:
- $2,973,622.50
Most recent insider trade:
- Aug. 14, 2024
Matthew L Posard's Insider Trading History
| Halozyme Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 14, 2024 | Director | 9,881 | $57.70 | Sell | $570,133.70 |
Aug. 12, 2024 | Director | 10,000 | $55.72 | Sell | $557,200.00 |
June 11, 2024 | Director | 10,000 | $50.01 | Sell | $500,100.00 |
Dec. 5, 2022 | Director | 10,000 | $55.74 | Sell | $557,400.00 |
Dec. 2, 2022 | Director | 10,000 | $58.80 | Sell | $588,000.00 |
| Nautilus Biotechnology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 30, 2021 | Director | 20,000 | $4.57 | Buy | $91,400.00 |
| DermTech Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 11, 2021 | Director | 33,898 | $29.50 | Buy | $999,991.00 |
| Illumina Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 30, 2013 | SVP | 2,836 | $70.80 | Sell | $200,788.80 |